Medivation In Talks With Sanofi After Rejecting Its $9.3B Offer
Medivation Inc. said Tuesday that it has entered into a confidentiality agreement with Sanofi SA and others, after the cancer-drug maker rejected a $9.3 billion merger offer from Sanofi and resisted...To view the full article, register now.
Already a subscriber? Click here to view full article